Literature DB >> 9063876

Association of domains within the cystic fibrosis transmembrane conductance regulator.

L S Ostedgaard1, D P Rich, L G DeBerg, M J Welsh.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl- channel composed of two membrane-spanning domains (MSD), two nucleotide-binding domains (NBD), and an R domain. To understand how these domains interact, we expressed various constructs of CFTR containing membrane-spanning and/or cytosolic domains either separately or together. We then tested for functional association of these domains using the SPQ halide-efflux assay or physical association using coimmunoprecipitation experiments. Coexpression of the amino-terminal half (MSD1, NBD1, and the R domain) and the carboxy-terminal half (MSD2 and NBD2) of CFTR generated functional Cl- channel activity whereas expression of either alone did not give a signal with the SPQ assay. This result suggests that the two halves associate in the membrane. Using domain-specific antibodies, we found that either half of CFTR could coimmunoprecipitate the other, suggesting a physical association. Coimmunoprecipitation persisted between halves missing the NBDs, the R domain, or the amino-terminal tail. Moreover, constructs from MSD1 containing only the first and second transmembrane sequences and intervening extracellular loop were sufficient for interaction with MSD2. These data suggest that interactions between the two membrane-spanning domains of CFTR may mediate association between the two halves of the protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063876     DOI: 10.1021/bi962174s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.

Authors:  Allan L Berger; Mutsuhiro Ikuma; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

Review 2.  The ABC protein turned chloride channel whose failure causes cystic fibrosis.

Authors:  David C Gadsby; Paola Vergani; László Csanády
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

3.  The Na+-phosphate cotransport system (NaPi-II) with a cleaved protein backbone: implications on function and membrane insertion.

Authors:  B Kohl; C A Wagner; B Huelseweh; A E Busch; A Werner
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

4.  Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.

Authors:  László Csanády; Kim W Chan; Angus C Nairn; David C Gadsby
Journal:  J Gen Physiol       Date:  2004-12-13       Impact factor: 4.086

5.  Phosphorylation of CFTR by PKA promotes binding of the regulatory domain.

Authors:  Valerie Chappe; Thomas Irvine; Jie Liao; Alexandra Evagelidis; John W Hanrahan
Journal:  EMBO J       Date:  2005-07-07       Impact factor: 11.598

Review 6.  Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein.

Authors:  F S Seibert; T W Loo; D M Clarke; J R Riordan
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

7.  Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator.

Authors:  Hal A Lewis; Sean G Buchanan; Stephen K Burley; Kris Conners; Mark Dickey; Michael Dorwart; Richard Fowler; Xia Gao; William B Guggino; Wayne A Hendrickson; John F Hunt; Margaret C Kearins; Don Lorimer; Peter C Maloney; Kai W Post; Kanagalaghatta R Rajashankar; Marc E Rutter; J Michael Sauder; Stephanie Shriver; Patrick H Thibodeau; Philip J Thomas; Marie Zhang; Xun Zhao; Spencer Emtage
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

8.  The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain.

Authors:  Hanneke Hoelen; Bertrand Kleizen; Andre Schmidt; John Richardson; Paraskevi Charitou; Philip J Thomas; Ineke Braakman
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.

Authors:  Estelle Cormet-Boyaka; Michael Jablonsky; Anjaparavanda P Naren; Patricia L Jackson; Donald D Muccio; Kevin L Kirk
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

Review 10.  Cystic fibrosis transmembrane conductance regulator (ABCC7) structure.

Authors:  John F Hunt; Chi Wang; Robert C Ford
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.